Use of Kv1.3 Blockers for Inflammatory Skin Conditions

Current Medicinal Chemistry - United Arab Emirates
doi 10.2174/092986710792065072
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bentham Science Publishers Ltd.

Related search

Activated T-Cells Inhibit Neurogenesis by Releasing Granzyme B: Rescue by Kv1.3 Blockers

Journal of Neuroscience
Neuroscience
2010English

Letter: Skin Reactions to Beta-Blockers.

BMJ
1974English

Voltage-Dependent Conformational Changes of KV1.3 Potassium Channels Are an Essential Element for KV1.3-induced Cell Proliferation

Biophysical Journal
Biophysics
2018English

Comorbid Infections of Pediatric Inflammatory Skin Diseases

Pediatric Annals
Child HealthPediatricsPerinatology
2012English

Skin Prick Testing in Patients Using Beta-Blockers: A Retrospective Analysis

Allergy, Asthma and Clinical Immunology
ImmunologyPulmonaryAllergyRespiratory Medicine
2010English

Common Conditions in Skin of Color

Seminars in Cutaneous Medicine and Surgery
DermatologyMedicineSurgery
2016English

Sun Exposure, Skin Cancers and Related Skin Conditions

Journal of Epidemiology
MedicineEpidemiology
1999English

Deciphering the Kv1.3/Caveolin Interaction

Biophysical Journal
Biophysics
2017English

Surgical Treatment of Malignant Skin Conditions.

BMJ
1985English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy